Brief: CombiGene’s Lipodystrophy Project Gets EUR 882,500 In Development Funding From EU Eurostar Program

Larkberget AB

22/02/2021 08:03

Feb 22 (Reuters) - Combigene AB  COMBI.ST :
    * COMBIGENE’S LIPODYSTROPHY PROJECT RECEIVES EUR 882,500 IN
DEVELOPMENT FUNDING FROM THE EU EUROSTAR PROGRAM
    * COMBIGENES PROJECT CGT2 AIMS TO DEVELOP A GENE THERAPY FOR
TREATMENT OF RARE DISEASE PARTIAL LIPODYSTROPHY.
    * IS AWARDED EUR 481,000 IN PROJECT GRANTS
    * MONEY IS DISTRIBUTED TO COMBIGENE WITH EUR 481,000,
ACCELERO
WITH EUR 136,500 AND UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF
WITH EUR 265,000.
    * BROADENS COOPERATION IN LIPODYSTROPHY PROJECT TO INCLUDE
UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF AND CRO COMPANY
ACCELERO, WHO RECEIVES EUR 265,000 AND EUR 136,500 RESPECTIVELY
WITHIN SAME PROJECT GRANT

Source text for Eikon:  ID:nMFN63Y6Sr 
Further company coverage:  COMBI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))